Related Experiment Video

Updated: Jun 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Metformin induces suppression of NAD(P)H oxidase activity in podocytes

Agnieszka Piwkowska1, Dorota Rogacka, Maciej Jankowski

  • 1Mossakowski Medical Research Centre Polish Academy of Sciences, Gdańsk, Poland. apiwkowska@cmdik.pan.pl

Biochemical and Biophysical Research Communications
|February 4, 2010
PubMed

Insights

Metformin reduces harmful reactive oxygen species (ROS) in diabetic kidney cells by decreasing NAD(P)H oxidase activity. This mechanism involves AMP-dependent kinase (AMPK) activation, offering potential benefits for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Diabetology
  • Biochemistry

Background:

  • Diabetic nephropathy is characterized by increased reactive oxygen species (ROS) production in kidney podocytes, primarily from NAD(P)H oxidase.
  • Hyperglycemia exacerbates ROS production, contributing to kidney damage in diabetes.

Purpose of the Study:

  • To investigate the effect of metformin on superoxide anion production in cultured podocytes.
  • To elucidate the underlying mechanisms of metformin's action, focusing on NAD(P)H oxidase and AMP-dependent kinase (AMPK) pathways.

Main Methods:

  • Cultured podocytes were exposed to normal (NG) and high glucose (HG) conditions.
  • Reactive oxygen species (ROS) production was measured using a DCF probe.
  • NAD(P)H oxidase activity was assessed via chemiluminescence.
  • AMPK activity was determined by immunoblotting for phosphorylated AMPK.
  • The role of AMPK was confirmed using an AMPK inhibitor (compound C).

Main Results:

  • High glucose significantly increased ROS production in podocytes.
  • Metformin markedly reduced ROS production under both normal and high glucose conditions.
  • Metformin decreased NAD(P)H oxidase activity and increased AMPK activity.
  • The effects of metformin on NAD(P)H oxidase and AMPK were dependent on AMPK activation.

Conclusions:

  • Metformin effectively reduces ROS production in podocytes by inhibiting NAD(P)H oxidase activity.
  • AMPK activation is a key mechanism mediating metformin's protective effects against hyperglycemia-induced oxidative stress.
  • These findings highlight metformin's potential therapeutic role in managing diabetic nephropathy.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...